Showing 2,881 - 2,900 results of 3,784 for search '"hypertension"', query time: 0.07s Refine Results
  1. 2881
  2. 2882

    An implementation trial to mAnage siCkle CELl disEase through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE): Study protocol. by Emmanuel Peprah, Joyce Gyamfi, John Patena, Hazal Kayalioglu, Tania Hameed, Gbenga Ogedegbe, Hyungrok Do, Dike Ojji, Deborah Adenikinju, Tayo Ajaye Oba, Maxwell Nwegbu, Hezekiah Isa, Grace Shedul, Alayo Y Sopekan, Obiageli E Nnodu

    Published 2025-01-01
    “…<h4>Methods</h4>This study will implement the SIM intervention, encompassing patient screening, initiation of HU treatment, and maintenance of dosage, which will be implemented via the TAsk-Strengthening Strategy for Hemoglobinopathies (TASSH TCP), derived from our team's TAsk-Strengthening Strategy for Hypertension control (TASSH) trials. Employing a sequential exploratory mixed-methods approach within the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework, this study will assess SIM adoption by providers in Nigeria. …”
    Get full text
    Article
  3. 2883

    Prevalence and associated factors of epiretinal membrane using spectralis OCT in Fujian Eye Study by Yang Li, Xiaoxin Li, Yonghua Hu, Bin Wang, Mingqin Zhang, Qinrui Hu

    Published 2025-02-01
    “…Multiple logistic regression showed the presence of ERM was only associated with urbanization and geographic location, but not with age, sex, refractive error, IOP, SBP, DBP, HR, BMI, hypertension, diabetic mellitus, hyperlipidemia, education, income, smoking, alcohol and tea consumption. …”
    Get full text
    Article
  4. 2884

    Molecular Modeling Studies of Substituted 2,4,5-Trisubstituted Triazolinones Aryl and Nonaryl Derivatives as Angiotensin II AT1 Receptor Antagonists by Mukesh C. Sharma, D. V. Kohli, Smita Sharma

    Published 2013-01-01
    “…The development of new therapies to treat hypertension and cardiovascular diseases. A series of 2,4,5-trisubstituted triazolinones aryl and nonaryl derivatives were subjected to Group-based QSAR, k-nearest neighbour molecular field analysis, and pharmacophore mapping. …”
    Get full text
    Article
  5. 2885

    The Relation of Coffee Consumption to Serum Uric Acid in Japanese Men and Women Aged 49–76 Years by Ngoc Minh Pham, Daigo Yoshida, Makiko Morita, Guang Yin, Kengo Toyomura, Keizo Ohnaka, Ryoichi Takayanagi, Suminori Kono

    Published 2010-01-01
    “…Statistical adjustment was made for body mass index, alcohol use, hypertension, diabetes mellitus, and other factors. Results. …”
    Get full text
    Article
  6. 2886

    Ultrasonography of Optic Nerve Sheath Diameter in Healthy Volunteers by Ariel Sosa Remón, Wilfredo Boch Rodríguez, Dasha María García Arias, Carmen Esther Remón Chávez, Ana Esperanza Jerez Álvarez, Arian Jesús Cuba Naranjo

    Published 2023-12-01
    “…One of the deficiencies stated is the non-existence of a standard value that suggests the limit between normality and intracranial hypertension. <br /><strong>Objective:</strong> determine the diameter of the optic nerve sheath using ultrasound in healthy volunteers. …”
    Get full text
    Article
  7. 2887
  8. 2888

    New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx by Sagar Changela, Samad Ashraf, Justin Y. Lu, Kevin E. Duong, Sonya Henry, Stephen H. Wang, Tim Q. Duong

    Published 2024-12-01
    “…COVID-19 patients had an elevated risk of developing new GID (adjusted HR = 1.18 (95% CI 1.12–1.25) compared to propensity-matched controls, after adjusting for confounders that included smoking, obesity, diabetes, hypertension. These findings underscore the need for additional research and follow-up of at-risk individuals for developing GID post infection.…”
    Get full text
    Article
  9. 2889

    Uncoded chronic kidney disease prevalence in secondary care: a retrospective audit with population health implications by Samantha Dolan, Ajitesh Anand, Philip A. Kalra, Stuart Stewart

    Published 2025-01-01
    “…Conversion of uncoded to coded CKD at discharge was only 6.7%. Hypertension and advanced CKD were significant predictors of coding CKD on discharge in uncoded patients. …”
    Get full text
    Article
  10. 2890

    The Renal and Liver Complications Development among Patients with Type 2 Diabetes Mellitus in Kirkuk City by Wasan Talib Abed, Walaa Esmael Jassim, Emad Mohamed Rasheed

    Published 2022-06-01
    “…The hospital-based cases- control study was conducted for patients with T2DM patients that attended the diabetic clinics in Kirkuk during the period from March 2021– to August 2021 and were screened for serum conc. of liver function tests (Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST) and Alkaline Phosphatase (ALP)), renal function tests (Creatinine and Urea) especially with (family history of diabetes, & hypertension.  Patients recruited for this study, showed serum urea and creatinine significantly more than that in control, p < .001, while for renal glomerular filtration rates significantly lower than that in control group, p < 001. …”
    Get full text
    Article
  11. 2891

    Influence of Artificial Sweetener on Human Blood Glucose Concentration by Ilse Skokan, P. Christian Endler, Beatrix Wulkersdorfer, Dieter Magometschnigg, Heinz Spranger

    Published 2007-01-01
    “…In this pilot-study 16 patients were included suffering from adiposity, pre-diabetes and hypertension. In the sense of a cross-over design, three test trials were performed at intervals of several weeks. …”
    Get full text
    Article
  12. 2892

    Risk Factors for Macro- and Microvascular Complications among Older Adults with Diagnosed Type 2 Diabetes: Findings from The Irish Longitudinal Study on Ageing by Marsha L. Tracey, Sheena M. McHugh, Anthony P. Fitzgerald, Claire M. Buckley, Ronan J. Canavan, Patricia M. Kearney

    Published 2016-01-01
    “…Diabetes diagnosis of 10 or more years, a history of smoking, and a diagnosis of hypertension were associated with an increased risk of microvascular complications. …”
    Get full text
    Article
  13. 2893

    Smoking as a causative factor in chronic kidney disease: a two-sample Mendelian randomization study by Yue Yang, Zheng Zhang, Hai-tao Lu, Qian-qian Xu, Li Zhuo, Wen-ge Li

    Published 2025-12-01
    “…Additionally, the effect of smoking on CKD was mediated by factors such as body mass index, cardiovascular disease, hypertension, and type 2 diabetes. These findings identify smoking as a contributing factor to CKD and suggest that reducing smoking prevalence could significantly lower the incidence of CKD in the population.…”
    Get full text
    Article
  14. 2894

    Uremic Leontiasis Ossea due to Resistant Secondary Hyperparathyroidism by Kubra Tuna, MD, Olesya Ilkun, MD, PhD, Peter T. Dziegielewski, MD, Anu Sharma, MD

    Published 2025-01-01
    “…Case Report: A 48-year-old woman with a history of hypertension, coronary artery disease, and ESRD on hemodialysis presented with severe secondary hyperparathyroidism and calciphylaxis. …”
    Get full text
    Article
  15. 2895

    A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation by Bertram L. Kasiske, Bjorn Nashan, Maria Del Carmen Rial, Pablo Raffaele, Graeme Russ, Josep Campistol, Mark D. Pescovitz, Paul A. Keown

    Published 2012-01-01
    “…The most common adverse events were hypertension (47%), hyperlipidemia (26%), urinary tract infections (25%), anaemia (24%) and diarrhea (14%), and cardiac events, hyperlipemia and CMV infection were more common in patients converted during the first year. …”
    Get full text
    Article
  16. 2896

    The Guyana Diabetes and Foot Care Project: Improved Diabetic Foot Evaluation Reduces Amputation Rates by Two-Thirds in a Lower Middle Income Country by Julia Lowe, R. Gary Sibbald, Nashwah Y. Taha, Gerald Lebovic, Madan Rambaran, Carlos Martin, Indira Bhoj, Brian Ostrow

    Published 2015-01-01
    “…Phase 2: Regionalization to cover 90% of the Guyanese population and expansion to include improved management of diabetes and hypertension. Fourteen key opinion leaders were educated and 340 health care professionals from 97 facilities trained. …”
    Get full text
    Article
  17. 2897

    Liver lobes and cirrhosis: Diagnostic insights from lobar ratios by Kriti Pandey, Debabrata Dash, Raj Kumar Koiri

    Published 2025-01-01
    “…Cirrhosis primarily causes portal hypertension which has a varying impact on the four lobes. …”
    Get full text
    Article
  18. 2898

    Epidemiology and risk factors of diabetic retinopathy in upper Egypt: a 3-year prospective study by Hassan S. Yousef, Mohamed E. Ahmed, Esam A. G. Abu El Wafa, Mohamed A. K. Salih

    Published 2024-05-01
    “…Also, DR was significantly associated with insulin use, moderate and poor control of diabetes mellitus, uncontrolled hypertension (HTN), dyslipidemia, and nephropathy (P<0.01 for all). …”
    Get full text
    Article
  19. 2899
  20. 2900

    Specialized Medical Weight Management Intervention for High-Risk Obesity by Gitanjali Srivastava, Chelsea Paris, Jessica Johnson, Emma Barnes, Brittany L. Cunningham, C. J. Stimson, Kevin D. Niswender, Sabrina J. Poon

    Published 2021-07-01
    “…The prevalence of any obesity-related medical condition was 54.1%; at least a quarter of the patients had either prediabetes or Type 2 diabetes mellitus, approximately a third had hypertension, and over 8% had hyperlipidemia. Mean weight loss from the initial program start date was 6.28% (+/-0.48% standard error of mean [SEM]; 95% confidence interval [CI] 5.34-7.23%). …”
    Get full text
    Article